Cassandra Jardine's contribution to the evaluation of a new cancer treatment was not in vain The late Cassandra Jardine, who wrote for The Daily Telegraph, was treated for non-smoking-related adenocarcinoma of the lung By James Le Fanu 6:53PM GMT 09 Dec 2012 Comments The necessity to test formally the efficacy of new drugs in controlled clinical trials is self-evident. Still, it can be very frustrating for those involved as many will recall from reading the late Cassandra Jardine’s characteristically brilliant (and funny) account earlier this year of her experience being treated for non-smoking-related adenocarcinoma of the lung. Cass drew the short straw being allocated to...
0 Responses to Doctor's Diary: testing new drugs can be frustrating